Bloomage BioTechnology Corporation Limited (SHA:688363)
China
· Delayed Price · Currency is CNY 43.35
+0.11 (0.25%)
Apr 29, 2026, 3:00 PM CST
SHA:688363 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 4,199 | 5,361 | 6,075 | 6,359 | 4,947 | Upgrade
|
| Other Revenue | - | 9.49 | 0.6 | 0.41 | 0.55 | Upgrade
|
| Revenue | 4,199 | 5,371 | 6,076 | 6,359 | 4,948 | Upgrade
|
| Revenue Growth (YoY) | -21.82% | -11.61% | -4.45% | 28.53% | 87.93% | Upgrade
|
| Cost of Revenue | 1,246 | 1,482 | 1,659 | 1,482 | 1,118 | Upgrade
|
| Gross Profit | 2,953 | 3,889 | 4,417 | 4,877 | 3,829 | Upgrade
|
| Selling, General & Admin | 2,057 | 3,118 | 3,331 | 3,439 | 2,736 | Upgrade
|
| Research & Development | 472.14 | 466.25 | 446.35 | 388.19 | 284.34 | Upgrade
|
| Other Operating Expenses | -34.75 | 46.48 | 62.01 | 73.25 | 56.95 | Upgrade
|
| Operating Expenses | 2,494 | 3,656 | 3,847 | 3,915 | 3,083 | Upgrade
|
| Operating Income | 459.21 | 232.36 | 570.18 | 961.48 | 746.46 | Upgrade
|
| Interest Expense | - | -9.17 | -10.74 | -14.52 | -11.08 | Upgrade
|
| Interest & Investment Income | - | 14.11 | 39.78 | 50.44 | 45.07 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 2.97 | 3.9 | 25.19 | -12.05 | Upgrade
|
| Other Non Operating Income (Expenses) | -31.73 | -4.76 | 1.71 | -3.88 | -2.62 | Upgrade
|
| EBT Excluding Unusual Items | 427.49 | 235.51 | 604.84 | 1,019 | 765.77 | Upgrade
|
| Impairment of Goodwill | - | -74.09 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 14.15 | -11.48 | -18.74 | -0.14 | 7.39 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.22 | -0.11 | -3.42 | -0.24 | 0.04 | Upgrade
|
| Asset Writedown | -108.05 | -0.86 | -1.87 | -0.53 | -3.91 | Upgrade
|
| Other Unusual Items | - | 64.43 | 120.91 | 118.32 | 120.9 | Upgrade
|
| Pretax Income | 333.8 | 213.39 | 701.72 | 1,136 | 890.2 | Upgrade
|
| Income Tax Expense | 42.65 | 44.99 | 118.98 | 174.73 | 114.64 | Upgrade
|
| Earnings From Continuing Operations | 291.15 | 168.41 | 582.74 | 961.38 | 775.56 | Upgrade
|
| Minority Interest in Earnings | 0.91 | 5.86 | 9.81 | 9.54 | 6.78 | Upgrade
|
| Net Income | 292.06 | 174.27 | 592.56 | 970.92 | 782.33 | Upgrade
|
| Net Income to Common | 292.06 | 174.27 | 592.56 | 970.92 | 782.33 | Upgrade
|
| Net Income Growth | 67.59% | -70.59% | -38.97% | 24.10% | 21.14% | Upgrade
|
| Shares Outstanding (Basic) | 479 | 484 | 482 | 481 | 480 | Upgrade
|
| Shares Outstanding (Diluted) | 479 | 484 | 482 | 483 | 483 | Upgrade
|
| Shares Change (YoY) | -1.09% | 0.48% | -0.27% | 0.03% | 0.95% | Upgrade
|
| EPS (Basic) | 0.61 | 0.36 | 1.23 | 2.02 | 1.63 | Upgrade
|
| EPS (Diluted) | 0.61 | 0.36 | 1.23 | 2.01 | 1.62 | Upgrade
|
| EPS Growth | 69.44% | -70.73% | -38.81% | 24.07% | 20.00% | Upgrade
|
| Free Cash Flow | 301.77 | -156.88 | -330.68 | -61.22 | 491.85 | Upgrade
|
| Free Cash Flow Per Share | 0.63 | -0.32 | -0.69 | -0.13 | 1.02 | Upgrade
|
| Dividend Per Share | - | 0.110 | 0.380 | 0.610 | 0.490 | Upgrade
|
| Dividend Growth | - | -71.05% | -37.70% | 24.49% | 19.51% | Upgrade
|
| Gross Margin | 70.33% | 72.41% | 72.69% | 76.69% | 77.40% | Upgrade
|
| Operating Margin | 10.94% | 4.33% | 9.38% | 15.12% | 15.09% | Upgrade
|
| Profit Margin | 6.96% | 3.25% | 9.75% | 15.27% | 15.81% | Upgrade
|
| Free Cash Flow Margin | 7.19% | -2.92% | -5.44% | -0.96% | 9.94% | Upgrade
|
| EBITDA | 769.4 | 465.45 | 775.49 | 1,124 | 866.92 | Upgrade
|
| EBITDA Margin | 18.32% | 8.67% | 12.76% | 17.68% | 17.52% | Upgrade
|
| D&A For EBITDA | 310.19 | 233.1 | 205.31 | 162.69 | 120.46 | Upgrade
|
| EBIT | 459.21 | 232.36 | 570.18 | 961.48 | 746.46 | Upgrade
|
| EBIT Margin | 10.94% | 4.33% | 9.38% | 15.12% | 15.09% | Upgrade
|
| Effective Tax Rate | 12.78% | 21.08% | 16.96% | 15.38% | 12.88% | Upgrade
|
| Revenue as Reported | - | 5,371 | 6,076 | 6,359 | 4,948 | Upgrade
|
| Advertising Expenses | - | 1,377 | 1,790 | 2,051 | 1,583 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.